Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock?

Voyager Therapeutics (VYGR) shares ended the last trading session 11.6% higher at $5.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 18.1% gain over the past four weeks.The sudden surge in the stock price likely reflects the growing investor optimism regarding the potential of Voyager Therapeutics’ only clinical-pipeline candidate, VY7523 (anti-tau antibody), which is being developed in an early-stage study for treating Alzheimer’s disease.This gene therapy company is expected to post quarterly loss of $0.53 per share in its upcoming report, which represents a year-over-year change of -231.3%. Revenues are expected to be $8.51 million, down 65.4% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Voyager Therapeutics, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on VYGR going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Voyager Therapeutics is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Alvotech (ALVO), finished the last trading session 0.5% higher at $8.68. ALVO has returned 6.5% over the past month.For Alvotech, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.08. This represents a change of -57.9% from what the company reported a year ago. Alvotech currently has a Zacks Rank of #3 (Hold).Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Voyager Therapeutics, Inc. (VYGR): Free Stock Analysis Report Alvotech (ALVO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks